Matthew Lamont is managing director at DownUnder GeoSolutions' which just opened its new, powerful data center west of Houston. Courtesy of DUG

DownUnder GeoSolutions has officially opened its new data centre in Skybox Houston in Katy, Texas. It's being billed as one of the most powerful supercomputers on earth.

The center, which houses DUG's geophysical cloud service, DUG McCloud, celebrated its grand opening on Thursday, May 16. The company's data hall has 15 megawatts of power and resides in a building designed to withstand hurricane-force winds up to 190 mph.

A second, identical hall is already planned to be built out later this year. Together, the two machines will have a capacity of 650 petaflop, which is a measurement of computing speed that's equal to one thousand million million floating-point operations per second.

In addition to the second hall, DUG is working to build another giant computing system with exaflop capacity — a billion billion calculations per second — by 2021.

"We are in a race to build the first exascale supercomputing system," says Phil Schwan, CTO for DUG, in a news release.

Australia-based DUG first started construction on Bubba, the nickname for the machine, last year and chose Skybox Datacenters as the facility to put Bubba in after a global search. The supercomputer landing in Houston represented the largest data center transaction in the Houston area's history. Dallas-Fort Worth, Austin, and San Antonio have long overshadowed Houston as hotspots for data center activity in Texas.

An differentiating asset of Bubba is the cooling process, which reduces energy usage and costs. Thirteen miles of pipes connect the hard drives to 20-foot cooling towers. Bubba uses "its own patented immersion system that submerges the computer nodes in more than 700 specially-designed tanks filled with polyalphaolefin dielectric fluid," according to the release.

"The complete DUG Insight software suite is available, and is fully-optimised to run on the cloud," says DUG's managing director, Matthew Lamont.

DUG's device is based on Intel® Xeon® processors, and the company uses Intel's technology to enhance its services, and there are more than 40,000 Intel Xeon processor nodes within the DUG McCloud network.

"The close collaboration between our two companies ensures DUG customers have access to the compute resources needed to obtain more meaningful insights from the geophysical landscapes they are exploring," says Trish Damkroger, vice president and general manager of Intel's Extreme Computing Organization, in a release.

"The Bubba supercomputer is a tremendous addition to the DUG McCloud network, and we look forward to our continued collaboration to build even more powerful systems to help accelerate this research and development."

Super-sized supercomputer

Natalie Harms/InnovationMap

Bubba, as the machine is called, has 15 megawatts of power and resides in a building designed to withstand hurricane-force winds up to 190 mph.

DownUnder GeoSolutions, which has its U.S. headquarters in Houston, is getting ready to flip the switch on what is being billed as the world's fastest supercomputer. Photo via DUG.com

World's fastest supercomputer is getting ready to power on in Houston

Booting up

An Australian company that provides geoscience and tech services to the oil and gas industry is gearing up to flip the switch in Katy on what's being billed as the world's fastest supercomputer.

At the 20-acre Skybox Houston data center campus in the Energy Corridor, DownUnder GeoSolutions is assembling a 15-megawatt data center that will house more than 40,000 servers to create the world's fastest supercomputer. Houston is the U.S. headquarters for DUG.

The data center will power a cloud computing service, known as DUG McCloud, that's tailored to the geosciences sector. The company says DUG McCloud will supply "enormous" computing capacity and high-performance storage for DUG's cloud business.

Construction on DUG McCloud — which has been delayed due to recent heavy rains — is set to be completed in April, according to the company's blog.

"DUG McCloud will be available to external companies to expand their computational resources on demand," the company says on its blog. "In addition, the cloud service will give clients access to DUG's proprietary software, with the option of source code, to accelerate their research, development, and production."

DUG McCloud is being touted as the world's biggest cloud computing service for the oil and gas industry. Among its prospective clients are global oil companies, government-owned oil producers, seismic contractors, and data companies.

"DUG McCloud is offering a wide range of companies the opportunity to significantly accelerate their oil and gas projects with cutting-edge geophysical software, stacked with extraordinary supercomputer power and services," Mick Lambert, the newly hired manager of DUG McCloud, said in December.

So, just how extraordinary will DUG's new supercomputer be?

DUG's equipment — contained in a building designed to withstand hurricane-force winds up to 190 mph — will offer more than 250 single-precision petaflops of computing speed, or 250,000 trillion calculations per second.

For now, the world's fastest supercomputer is Summit, a collaboration between the U.S. Department of Energy and IBM. Its top speed is 200 petaflops. Summit operates at Oak Ridge National Laboratory in Tennessee.

Over the long term, DUG envisions its data center being able to handle exascale computing, capable of generating at least 1 quintillion calculations per second. A quintillion has twice as many zeroes as a billion does. China is set to debut the world's first exascale supercomputer in 2020 — a year ahead of the first one to be established in the U.S., a $500 million public-private project called Aurora being developed by the Department of Energy and Intel.

DUG's deal for its data center in Katy represents the largest data center transaction in the Houston area's history. Dallas-Fort Worth, Austin, and San Antonio have long overshadowed Houston as hotspots for data center activity in Texas.

Matthew Lamont, co-founder of DUG, said in October that the company conducted an "exhaustive" search for the data center. "Houston was a natural choice," he said, "given the low cost of power and the fact that Skybox had the available infrastructure ready to go."

A unique feature of DUG's data center is how the servers will be cooled. The company's patent-pending DUG Cool system will immerse all of the servers in custom-designed tanks filled with an environmentally friendly cooling fluid.

DUG says this fluid enables condensed water-cooling chillers to be used to cool the servers, rather than server fans and refrigeration units. This will reduce energy consumption by 45 percent compared with traditional air-cooled systems, according to DUG.

"We like to call it the greenest cloud service in the world," Lamont said on DUG's blog. "DUG McCloud certainly offers more than just a silver lining."

The DUG center represents about 65 percent of the 23 megawatts of data center space under construction in the Houston area, according to a new report from commercial real estate services company CBRE.

"As high-performance computing continues to grow in importance to the energy sector, it is likely that additional latency-sensitive deployments will grow in the Houston market," Haynes Strader, senior associate at CBRE, says in a news release.

"Latency-sensitive" refers to the need for technology to act quickly in response to various events.

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

Houston digital health platform Koda lands strategic investment

money moves

Houston-based advance care planning platform Koda Health has added another investor to the lineup.

The company secured a strategic investment for an undisclosed amount from UPMC Enterprises, the commercialization arm of the University of Pittsburgh Medical Center. The funding is part of Koda's oversubscribed series A funding round that closed in October, according to a release.

"UPMC Enterprises’ investment is a meaningful signal, not just to Koda, but to the broader market," Dr. Desh Mohan, chief medical officer and co-founder of Koda Health, said in the news release. "It validates that health systems are ready to invest in infrastructure that makes advance care planning work the way it should: proactively, at scale, and with the human support that these conversations require. Having UPMC Enterprises as a strategic investor puts us in a unique position to prove what's possible."

Koda has raised $14 million to date, according to a representative from the company. Its series A round was led by Evidenced, with participation from Mudita Venture Partners, Techstars and the Texas Medical Center last year. At the time, the company said the funding would allow it to scale operations and expand engineering, clinical strategy and customer success. The company described the round as a "pivotal moment," as it had secured investments from influential leaders in the healthcare and venture capital space.

Koda Health, which was born out of the TMC's Biodesign Fellowship in 2020, saw major growth last year, as well, and now supports more than 1 million patients nationwide through partnerships with Cigna Healthcare, Privia Health, Guidehealth, Sentara, UPMC and Memorial Hermann Health System.

The company integrated its end-of-life care planning platform with Dallas-based Guidehealth in April 2025 and with Epic Systems in July 2025. It also won the 2025 Houston Innovation Award in the Health Tech Business category. Read more here.

New 'living pharmacy' biotech company launches out of Rice venture studio

fighting cancer

Rice University’s biotech venture studio RBL LLC has launched a new “living pharmacy” company, Duracyte, designed to make cancer treatment easier on patients.

Backed by an up to $45 million Advanced Research Projects Agency for Health (ARPA-H) award, Duracyte aims to commercialize implantable biohybrid pharmacy devices that are designed to produce therapeutic proteins inside the human body around the clock, replacing the need for regular injections and infusions for some cancer patients.

The company’s main platform is its Hybrid Advanced Molecular Manufacturing Regulator (HAMMR), a rechargeable, implantable device that can sense biological signals, monitor tumor environments and adjust therapeutic output in real time. HAMMR has wireless communication capabilities, which allow patients and clinicians to remotely monitor results through an app every five minutes and make changes to treatment plans without a hosptial visit. Additionally, the device can generate its own oxygen supply, which is key for the therapeutic cells’ survival.

“Biologic medicines such as monoclonal antibodies, cytokines and metabolic regulators already account for a significant share of modern therapeutics, but the way we deliver them today often requires frequent injections or infusions that can be demanding for patients and lead to inconsistent drug levels,” Daniel Anderson, MIT professor and co-founder of Duracyte, said in a news release. “Our vision is to enable a continuous, stable therapy by producing these medicines directly inside the body, which could improve treatment consistency, reduce side effects and ultimately transform how biologic therapies are delivered across many diseases.”

Duracyte’s first clinical trial is slated to begin by the end of 2026 and will focus on recurrent ovarian cancer. The Phase I study will build upon existing work on encapsulated cytokine pharmacy technology, and the company hopes that within a few years this treatment can reach clinical application.

The development of Duracyte is supported by ARPA-H's Targeted Hybrid Oncotherapeutic Regulation (THOR) project, which supports a multidisciplinary research consortium co-led by Omid Veiseh, a professor of bioengineering at Rice. The consortium also includes others at Rice, The University of Texas MD Anderson Cancer Center, Stanford University, Carnegie Mellon University, Northwestern University and the University of Houston, plus industry collaborators like Chicago-based CellTrans.

“What we are building is the culmination of years of progress in cell engineering, biomaterials and implantable device technology,” Veiseh added in the release. “By combining these advances with real-time sensing and adaptive drug delivery, we are working with the support of RBL to create a true ‘living pharmacy’ that can deliver continuous, precisely controlled biologic therapies and fundamentally change how these treatments reach patients.”

RBL launched in 2024 and is based out of Houston’s Texas Medical Center Helix Park. Duracyte is the third company launched by RBL, including Sentinel BioTherapeutics, a clinical-stage immunotherapy company developing localized cytokine therapies for solid tumors, and SteerBio, a regenerative medicine company targeting lymphedema.

“Duracyte exemplifies the kind of breakthrough that Houston’s ecosystem is built to produce,” Paul Wotton, managing partner of RBL LLC and co-founder of Duracyte, added in the release. “With world-class clinical infrastructure, exceptional engineering talent and initiatives like the Texas Biotech Task Force driving alignment across industry, investment and talent, this region is uniquely positioned to move the most ambitious ideas in medicine from concept to patient, faster than anywhere else.”